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Background
Significantly higher pharyngeal shedding of Epstein-Barr
virus (EBV) is observed during HIV infection. Increased
EBV shedding in pharynx is not affected even during
highly active antiretroviral theyrapy (HAART). EBV
positive monocyte populations have been shown to
carry EBV to pharyngeal mucosa. Human cytokine pro-
files are often altered to facilitate herpes virus infection.
Thus pharyngeal cytokine profiles may influence EBV
reactivation and shedding during HIV infection. Our
objective was to compare 37 pharyngeal cytokine pro-
files of HIV-seropositive patients who were or were not
receiving HAART therapy.
Methods
120 HIV positive volunteers under HAART and 72 HIV
patients not undergoing antiviral therapy were investi-
gated. All Volunteers with oral pathologies and smoking
were excluded. Pharyngeal secretions were collected
using standard procedures and analyzed for 37 cytokine
profiles using human cytokine profiler array panels and
ELISA. Cytokine interactome maps generated using
Ingenuity database.
Results
Proteome profiler arrays demonstrated differential cyto-
kine expression among HIV infected individual under
HAART, HIV infected individuals without HAART and
the healthy control. HIV group consisted of up regu-
lated C5a, G-CSF, CXCL1, soluble ICAM1, IL-1a,
IL-1b, IL1-Ra, IL-6, IL-8, IL-10, IL-12a, IL-13, IL-16, IL-
25, IL-23a, IL-27, IL-32a, CXCL10, CXCL11, CCL-13,
MIF, CCL3, CCL4, SERPIN-E1, CCL5, CXCL12, TNFa
and soluble TREM1 and down regulated soluble sCD40,
eGM-CSF, I-309, IFN-g, IL-17A, IL-2, IL-4, IL-5. From
these C5a, sTREM1, TNF alpha, CXCL12, CCL5, IL-17E,
IL-23, IL-32a, IL-16, CCL3, IL-6 showed significantly
higher expression levels in both HIV groups compared to
healthy group (P < 0.05). TGF b1 levels in HIV patients
undergoing HAART (0.5 +/-0.1 ng/ml) and without
HAART (0.4 +/-0.1 ng/ml) were significantly increased
when compared with the healthy control group (0.3 +/-
0.07 ng/ml) (P = 0.0001). TGF b1 levels had a significant
positive correlation with higher CD4 counts in the group
receiving HAART (P = 0.006). Cytokine interactome
mapping revealed significantly increased immune cell
trafficking in pharynx during HIV infection.
Conclusion
Pharyngeal TGF b1 levels are significantly increased
during HIV infection. As TGF b1 is a known trigger of
Epstein Barr viral lytic gene promoters, may influence
pharyngeal reactivation of Epstein-Barr virus. Addition-
ally, increased tendency for immune cell trafficking may
facilitate EBV positive monocyte trafficking towards
pharyngeal mucosa during HIV infection.
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